Expression of RET 3′ splicing variants during human kidney development

被引:27
作者
Ivanchuk, SM
Myers, SM
Mulligan, LM [1 ]
机构
[1] Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Paediat, Kingston, ON K7L 3N6, Canada
关键词
kidney; RET; alternative splicing;
D O I
10.1038/sj.onc.1201622
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mature mammalian kidney arises through a series of reciprocal inductive interactions between two different cell groups, the ureteric bud epithelium and the metanephric mesenchyme, The RET receptor tyrosine kinase is required for induction and development of the metanephric kidney. Differential splicing at the 3' end of RET results in transcripts encoding three isoforms that differ with respect to their C-terminal 9 (RET9), 51 (RET51) or 43 (RET43) amino acids, In vitro assays have identified differences in the abilities of the RET9 and RET51 isoforms to induce differentiation suggesting functional differences between these proteins. We examined the relative expression levels of the three RET 3' splicing variants in developing human kidney using semi-quantitative RT-PCR. We observed consistent expression of the RET9 and RET43 variants in kidney samples spanning 7.5 through 24 weeks gestation, At early gestational ages (7.5-8.5 weeks), RET51 expression was very low (+/-5%) compared to RET9; however, a rapid seven fold increase in expression was detected by 9 weeks. Our data suggest that RET51 may contribute to differentiation-related events occurring after 8.5 weeks gestation rather than to induction of the human kidney.
引用
收藏
页码:991 / 996
页数:6
相关论文
共 35 条
[1]   Identification of Shc docking site on Ret tyrosine kinase [J].
Arighi, E ;
Alberti, L ;
Torriti, F ;
Ghizzoni, S ;
Rizzetti, MG ;
Pelicci, G ;
Pasini, B ;
Bongarzone, I ;
Piutti, C ;
Pierotti, MA ;
Borrello, MG .
ONCOGENE, 1997, 14 (07) :773-782
[2]   DIVERSITY OF RET PROTOONCOGENE MUTATIONS IN FAMILIAL AND SPORADIC HIRSCHSPRUNG DISEASE [J].
ATTIE, T ;
PELET, A ;
EDERY, P ;
ENG, C ;
MULLIGAN, LM ;
AMIEL, J ;
BOUTRAND, L ;
BELDJORD, C ;
NIHOULFEKETE, C ;
MUNNICH, A ;
PONDER, BAJ ;
LYONNET, S .
HUMAN MOLECULAR GENETICS, 1995, 4 (08) :1381-1386
[3]  
AVANTAGGIATO V, 1994, CELL GROWTH DIFFER, V5, P305
[4]  
BORRELLO MG, 1994, ONCOGENE, V9, P1661
[5]  
Chakravarti A, 1996, HUM MOL GENET, V5, P303
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]   GDNF signalling through the Ret receptor tyrosine kinase [J].
Durbec, P ;
MarcosGutierrez, CV ;
Kilkenny, C ;
Grigoriou, M ;
Wartiovaara, K ;
Suvanto, P ;
Smith, D ;
Ponder, B ;
Costantini, F ;
Saarma, M ;
Sariola, H ;
Pachnis, V .
NATURE, 1996, 381 (6585) :789-793
[8]  
Durbec PL, 1996, DEVELOPMENT, V122, P349
[9]  
Eng C, 1997, HUM MUTAT, V9, P97, DOI 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.3.CO
[10]  
2-Q